GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Price-to-Operating-Cash-Flow

Raia Drogasil (BSP:RADL3) Price-to-Operating-Cash-Flow : 44.08 (As of Apr. 26, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Price-to-Operating-Cash-Flow?

As of today (2024-04-26), Raia Drogasil's share price is R$24.95. Raia Drogasil's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was R$0.57. Hence, Raia Drogasil's Price-to-Operating-Cash-Flow Ratio for today is 44.08.

The historical rank and industry rank for Raia Drogasil's Price-to-Operating-Cash-Flow or its related term are showing as below:

BSP:RADL3' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.84   Med: 33.01   Max: 408.77
Current: 44.08

During the past 13 years, Raia Drogasil's highest Price-to-Operating-Cash-Flow Ratio was 408.77. The lowest was 13.84. And the median was 33.01.

BSP:RADL3's Price-to-Operating-Cash-Flow is ranked worse than
85.37% of 451 companies
in the Healthcare Providers & Services industry
Industry Median: 12.78 vs BSP:RADL3: 44.08

Raia Drogasil's Cash Flow from Operations per share for the three months ended in Dec. 2023 was R$-0.09. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was R$0.57.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Raia Drogasil was 11.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -12.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.70% per year.

During the past 13 years, Raia Drogasil's highest 3-Year average Operating Cash Flow per Share Growth Rate was 85.90% per year. The lowest was -12.90% per year. And the median was 23.50% per year.


Raia Drogasil Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Raia Drogasil's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Price-to-Operating-Cash-Flow Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.24 28.03 25.82 44.90 51.76

Raia Drogasil Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.90 28.16 37.33 39.40 51.76

Competitive Comparison of Raia Drogasil's Price-to-Operating-Cash-Flow

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Price-to-Operating-Cash-Flow falls into.



Raia Drogasil Price-to-Operating-Cash-Flow Calculation

Raia Drogasil's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=24.95/0.566
=44.08

Raia Drogasil's Share Price of today is R$24.95.
Raia Drogasil's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Raia Drogasil Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines